Organon Cash Flow Statement
NYSE: OGNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Organon free cash flow
In fiscal 2025, Organon generated $700.0 million of operating cash flow and spent $162.0 million on capital expenditures. That left free cash flow of $538.0 million, a free-cash-flow margin of 8.7% of revenue. Free cash flow was down 29.6% from the prior year's $764.0 million.
Organon returned $88.0 million to shareholders through dividends, equal to 16% of free cash flow. Free cash flow covered dividend payments 6.1 times.
Summary generated from market data by MetaCap's automated system. Methodology
Organon cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 |
|---|---|---|---|---|---|---|---|
| Net Income | 187.00M | 864.00M | 1.02B | 917.00M | 1.35B | 2.16B | 3.22B |
| Net Income growth (YoY) | -78.36% | -15.54% | +11.56% | -32.12% | -37.45% | -32.88% | — |
| Depreciation & Amortization | 156.00M | 132.00M | 120.00M | 96.00M | 92.00M | 56.00M | 49.00M |
| Stock-Based Compensation | 77.00M | 105.00M | 101.00M | 75.00M | 59.00M | 40.00M | 41.00M |
| Change in Working Capital | -293.00M | -6.00M | -177.00M | -408.00M | 577.00M | 96.00M | -12.00M |
| Operating Cash Flow | 700.00M | 939.00M | 799.00M | 858.00M | 2.16B | 2.28B | 3.02B |
| Capital Expenditures | -162.00M | -175.00M | -251.00M | -196.00M | -192.00M | -255.00M | -92.00M |
| Investing Cash Flow | -390.00M | -513.00M | -260.00M | -420.00M | -481.00M | -250.00M | -88.00M |
| Dividends Paid | -88.00M | -297.00M | -294.00M | -290.00M | -145.00M | 0 | 0 |
| Debt Issued | 1.05B | 1.19B | 80.00M | 0 | 9.47B | 0 | 0 |
| Debt Repaid | -1.51B | -1.20B | -338.00M | -108.00M | -112.00M | 0 | 0 |
| Financing Cash Flow | -561.00M | -368.00M | -569.00M | -433.00M | -977.00M | -2.02B | -2.93B |
| Net Change in Cash | -101.00M | -18.00M | -13.00M | -31.00M | 667.00M | -249.00M | 75.00M |
| Free Cash Flow | 538.00M | 764.00M | 548.00M | 662.00M | 1.97B | 2.03B | 2.93B |
This table shows 7 annual periods of Organon's cash flow statement, from FY 2025 back to FY 2019, across 13 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow OGN's reporting calendar. What is a cash flow statement?